OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17: K+: H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis

Microbial Pathogenesis

Volumn 64, Issue , 2013, Pages 1-5

  Johnson, James R ^a,b   Russo, Thomas A ^c,d,e   Drawz, Sarah M ^b   Clabots, Connie ^a,b   Olson, Ruth ^d,e   Kuskowski, Michael A ^a,b   Rosen, Henry ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Clonal Group A; Escherichia coli infections; Extra urinary infections; OxyR; Urinary tract infections; Virulence

Indexed keywords

BACTERIAL PROTEIN; HYDROGEN PEROXIDE; PROTEIN OXYR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI O17; FEMALE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SKIN INFECTION; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

CLONAL GROUP A; ESCHERICHIA COLI INFECTIONS; EXTRA-URINARY INFECTIONS; OXYR; URINARY TRACT INFECTIONS; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENETIC COMPLEMENTATION TEST; MICE; REPRESSOR PROTEINS; SEPSIS; SKIN DISEASES, BACTERIAL; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 84880993551     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2013.07.001     Document Type: Article

References (38)

1. Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlooked epidemic. Microbe Infect 2003, 5:449-456.
2. Russo T.A., Johnson J.R. Aproposal for an inclusive designation for extraintestinal pathogenic Escherichia coli: ExPEC. JInfect Dis 2000, 181:1753-1754.
3. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli (ExPEC): the "other bad E.coli". JLab Clin Med 2002, 139:155-162.
4. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother 2009, 53:2733-2739.
5. Manges A.R., Johnson J.R., Foxman B., O'Bryan T.T., Fullerton K.E., Riley L.W. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. NEngl J Med 2001, 345:1007-1013.
6. Johnson J.R., Manges A.R., O'Bryan T.T., Riley L.R. Adisseminated multi-drug resistant clonal group of extraintestinal pathogenic Escherichia coli as a cause of pyelonephritis. Lancet 2002, 359:2249-2251.
7. Manges A.R., Dietrich P.S., Riley L.W. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infect Dis 2004, 38:329-334.
8. Manges A.R., Naterajan P., Solberg O.D., Dietrich P.S., Riley L.W. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiol Infect 2006, 134:425-432.
9. Manges A.R., Tabor H., Tellis P., Vincent C., Tellier P.-P. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 2008, 14:1575-1583.
10. Nicolas-Chanoine M.-H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. JAntimicrob Chemother 2008, 61:273-281.
11. Johnson J.R., Stell A.L., O'Bryan T.T., Kuskowski M., Nowicki B., Johnson C., et al. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. JClin Microbiol 2002, 40:1913-1923.
12. Johnson J.R., Murray A.C., Kuskowski M.A., Schubert S., Prere M.-F., Picard B., et al. Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis 2005, 11:141-145.
13. Wallace-Gadsden F., Johnson J.R., Wain J., Okeke I.N. Enteroaggregative Escherichia coli related to uropathogenic clonal group A. Emerg Infect Dis 2007, 13:757-760.
14. Boczek L.A., Rice E.W., Johnston B., Johnson J.R. Occurrence of antibiotic-resistant uropathogenic Escherichia coli clonal group A in wastewater effluents. Appl Environ Microbiol 2007, 73:4180-4184.
15. Lescat M., Calteau A., Hoede C., Barbe V., Touchon M., Rocha E., et al. Amodule located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A. Antimicrob Agents Chemother 2009, 53:2283-2288.
16. Johnson J.R., Johnston B., Clabots C., Kuskowski M.A., Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E.coli infections in the United States (2007). Clin Infect Dis 2010, 51:286-294.
17. Leveille S., Caza M., Johnson J.R., Clabots C., Sabri M., Dozois C.M. Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed invivo in the mouse urinary tract and functions as a catecholate siderophore receptor. Infect Immun 2006, 74:3427-3436.
18. Johnson J.R., Jelacic S., Schoening L.M., Clabots C., Mobley H.L.T., Tarr P.I. The IrgA homologue adhesin (Iha) is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun 2005, 73:965-971.
19. Storz G., Imlay J.A. Oxidative stress. Curr Opin Microbiol 1999, 2:188-194.
20. Johnson J.R., Clabots C., Rosen H. Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect Immun 2006, 74:461-468.
21. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000, 97:6640-6645.
22. Rosen H., Lewis P.J., Nitzel C.M. Neutrophil microbicidal activity: screening bacterial mutants for survival after phagocytosis using quantitative PCR. Jpn J Infect Dis 2004, 57:S19-S21.
23. Storz G., Christman M.F., Sies H., Ames B.N. Spontaneous mutagenesis and oxidative damage to DNA in Salmonella typhimurium. Proc Natl Acad Sci U S A 1987, 84:8917-8921.
24. Billips B.K., Forrestal S.G., Rycyk M.T., Johnson J.R., Klumpp D.J., Schaeffer A.J. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 2007, 75:5353-5360.
25. Spurbeck R.R., Stapleton A.E., Johnson J.R., Walk S.T., Hooton T.M., Mobley H.L. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 2011, 79:4753-4763.
26. Russo T.A., Beanan J.M., Olson R., MacDonald U., Luke N.R., Gill S.R., et al. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumanii biology. Infect Immun 2000, 76:3577-3586.
27. Johnson J.R., Porter S.B., Zhanel G., Kuskowski M.A., Denamur E. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012, 80:1554-1562.
28. Picard B., Garcia J.S., Gouriou S., Duriez P., Brahimi N., Bingen E., et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999, 67:546-553.
29. Johnson J.R., Russo T.A. Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. JInfect Dis 2002, 186:859-864.
30. Schembri M.A., Hjerrild L., Gjermansen M., Klemm P. Differential expression of the Escherichia coli autoaggregation factor antigen 43. JBacteriol 2003, 185:2236-2242.
31. Lüthje P., Brauner A. Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract. JClin Microbiol 2010, 48:2316-2317.
32. Seth D., Hausladen A., Wang Y.J., Stamler J.S. Endogenous protein S-Nitrosylation in E.coli: regulation by OxyR. Science 2012, 336:470-473.
33. Zheng M., Wang X., Templeton L.J., Smulski D.R., LaRossa R.A., Storz G. DNA microarray-mediated transcriptional profiling of the Escherichia coli response to hydrogen peroxide. JBacteriol 2001, 183:4562-4570.
34. Seaver L.C., Imlay J.A. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. JBacteriol 2001, 183:7173-7181.
35. Park S., You X., Imlay J.A. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx- mutants of Escherichia coli. Proc Natl Acad Sci U S A 2005, 102:9317-9322.
36. Stavropoulos T.A., Strathdee C.A. Expression of the tetA(C) tetracycline efflux pump in Escherichia coli confers osmotic sensitivity. FEMS Microbiol Lett 2000, 190:147-150.
37. Grüneberg R.N. Relationship of infecting urinary organism to the faecal flora in patients with symptomatic urinary infection. Lancet 1969, 1:766-768.
38. Yamamoto S., Tsukamoto T., Terai A., Kurazono H., Takeda Y., Yoshida O. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. JUrol 1997, 157:1127-1129.